INSULIN, BIPHASIC injectable

Prescription under medical supervision


Therapeutic action

– Pancreatic antidiabetic hormone: combination of short-acting + intermediate acting insulin 

Indications

– Diabetes

Forms and strengths, route of administration

– 1000 IU vial containing a combination of 30% short-acting insulin + 70% intermediate-acting insulin in suspension (100 IU/ml with a ratio of 30:70, 10 ml), for deep SC injection (abdomen, thigh, buttock or arm), administered with a syringe calibrated in insulin units for U-100 insulin (100 IU/ml).
NEVER ADMINISTER BY IV INJECTION.

Dosage

– Child and adult: one to 2 injections daily 
Dosage must be individualised according to need. Adapt dose in the event of physical activity, change in diet or infection.

Contra-indications, adverse effects, precautions

– See "Insulin: general information".
– Do not administer if known allergy to protamine.

Remarks

– After removing vial from the refrigerator, leave to reach room temperature.
– Shake the vial gently before use.
– Also comes in biphasic human insulin 30/70 pens and biphasic analogue insulin 30/70 (aspart) and 25/75 (lispro) pens. 
– Storage: do not freeze  - 
• Unopened vial: to be kept refrigerated (2 °C to 8 °C)
• Opened vial: max. 4 weeks at below 25 °C and protected from light. Follow manufacturer’s instructions.